Company intelligence / Profile preview

The Ibn Sina Pharmaceutical Industry

Dhaka, Dhaka, Bangladesh

Ownership: Private
Employees: ~5200
Development stage: Other

Overview

The Ibn Sina Pharmaceutical Industry is a leading pharmaceutical manufacturer in Bangladesh with a diversified portfolio of over 600 products, including 475 pharmaceutical and 135 natural medicines. The company operates state-of-the-art cGMP-compliant facilities and exports to 17 countries, including the USA. It has a significant presence in the generic market and is expanding into biotech and sterile injectables.

Therapeutic areas: HematologyImmunologyEndocrinologyCardiovascularInfectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
Modalities: Small moleculeNatural product
Industry: Biotech

Partnerships

Directorate General of Drug Administration (DGDA)Fette CompactingSejong PharmatechRomaco GroupIMA Group

Beyond the preview

Go deeper on The Ibn Sina Pharmaceutical Industry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Ibn Sina Pharmaceutical Industry.

Explore the full profile